Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals
The aim of the study was to analyze the overall survival (OS) and progression free survival (PFS) of patients with high grade and advanced stage epithelial ovarian cancer (EOC) with at least 60 months of follow-up treated in a single gynecologic oncology institute. We compared primary debulking surg...
Main Authors: | Kobal Borut, Noventa Marco, Cvjeticanin Branko, Barbic Matija, Meglic Leon, Herzog Marusa, Bordi Giulia, Vitagliano Amerigo, Saccardi Carlo, Skof Erik |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2018-09-01
|
Series: | Radiology and Oncology |
Subjects: | |
Online Access: | https://doi.org/10.2478/raon-2018-0030 |
Similar Items
-
Comparison of Survival Between Primary Debulking Surgery Versus Neoadjuvant Chemotherapy for Ovarian Cancers in a Personalized Treatment Cohort
by: Zheng Feng, et al.
Published: (2021-02-01) -
Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer
by: Kazuto Nakamura, et al.
Published: (2020-08-01) -
Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402)
by: Tomoko Hirakawa, et al.
Published: (2017-07-01) -
Primary debulking surgery for metastatic cervical adenocarcinoma: A case report
by: Sara M. Davenport, et al.
Published: (2015-11-01) -
A comparison between primary debulking surgery and primary chemotherapy in patients with advanced ovarian cancer: a retrospective study
by: Mohamed Esmat, et al.
Published: (2018-01-01)